Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

7.4%

17 terminated/withdrawn out of 229 trials

Success Rate

87.0%

+0.5% vs industry average

Late-Stage Pipeline

14%

31 trials in Phase 3/4

Results Transparency

3%

3 of 114 completed trials have results

Key Signals

38 recruiting3 with results13 terminated4 withdrawn

Enrollment Performance

Analytics

N/A
97(62.6%)
Phase 2
20(12.9%)
Phase 4
16(10.3%)
Phase 3
15(9.7%)
Phase 1
7(4.5%)
155Total
N/A(97)
Phase 2(20)
Phase 4(16)
Phase 3(15)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (229)

Showing 20 of 229 trials
NCT07577635Not Yet Recruiting

Impact of Iridotomy/Iridectomy Size on Postoperative Pupillary Block and Dysphotopsia Following DMEK

Role: lead

NCT05820841Phase 3Recruiting

Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell Lymphoma

Role: collaborator

NCT07622420Not Yet Recruiting

ProspectiveFemaleAYA - Late Effects of Cancer Therapies on Gonadal Function, Fertility, Efficiency of Fertility Preservation Procedures and Pregnancy Outcomes

Role: collaborator

NCT07622537Not Yet Recruiting

Late Effects of Cancer Therapies on Gonadal Function, Fertility, Efficiency of Fertility Preservation Procedures and Pregnancy Outcomes

Role: collaborator

NCT06822036Not ApplicableRecruiting

EFFICACY OF INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION ON THE POSTOPERATIVE BLOOD LOSS IN PATIENTS UNDERGOING RARP FOR THE TREATMENT OF PROSTATE CANCER

Role: collaborator

NCT07612943Not Yet Recruiting

ProspectiveMaleAYA - Frequency and Prediction of Therapy-induced Testicular Dysfunction in AYA Cancer Survivors

Role: collaborator

NCT04444492Phase 3Active Not Recruiting

Combination of Ranibizumab and Targeted Laser Photocoagulation

Role: collaborator

NCT06112171Not ApplicableRecruiting

Comparison of a Lithotripsy vs Standard Preparation Followed by Stenting With Supera Stent in Femoropopliteal Lesions

Role: lead

NCT06269263Not ApplicableCompleted

Feasibility of Home-based Cardiac Rehabilitation in Patients With Chronic Heart Failure (Pilot-CRHF)

Role: lead

NCT06656832Not ApplicableRecruiting

Peripheral Drivers of Heart Failure Progression - The Prospective PEDAL-HF Study

Role: lead

NCT03776799Not ApplicableActive Not Recruiting

BEST SFA Pilot Study - Best Endovascular STrategy for Complex Lesions of the Superficial Femoral Artery

Role: lead

NCT02083835Recruiting

PAIN OUT: Improvement in Postoperative PAIN OUTcome

Role: collaborator

NCT06056505Not ApplicableCompleted

Virtual Interactive 3D Modelling to Improve Outcomes in Robotic-Assisted Partial Nephrectomy

Role: lead

NCT06931938Not ApplicableRecruiting

Awake Prone Positioning in Spontaneous Breathing Patients With Acute Hypoxic Respiratory Failure Due to Pneumonia

Role: collaborator

NCT06576934Not ApplicableRecruiting

Early TIPS in Patients With Liver Cirrhosis and Ascites

Role: collaborator

NCT05833438Phase 2Active Not Recruiting

Venetoclax in Combination With 5 Days Azacitidine in Untreated AML Patients, Not Eligible for Standard Induction Therapy

Role: lead

NCT03469609Not ApplicableRecruiting

Mucous Fistula Refeeding Reduces the Time From Enterostomy Closure to Full Enteral Feeds ("MUC-FIRE" Trial)

Role: lead

NCT07155564Recruiting

Validation of Energy Expenditure Measures Study

Role: lead

NCT06832579Not ApplicableActive Not Recruiting

SmartWatch-driven AF Detection in Stroke Patients

Role: lead

NCT07549607Not Yet Recruiting

Clinical Characterization of Patients With Primary Biliary Cirrhosis Treated With Seladelpar in the Real-life Setting

Role: lead